Schedule 13G ownership disclosure

APPLIED THERAPEUTICS INC

Common Stock $0.0001 par value per share · CUSIP: 03828A101

Event date: 2024-12-31

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Venrock Healthcare Capital Partners III, L.P.

    Shares: 11,805,301.00 · Class: 9.9%

  • VHCP Co-Investment Holdings III, LLC

    Shares: 11,805,301.00 · Class: 9.9%

  • Venrock Healthcare Capital Partners EG, L.P.

    Shares: 11,805,301.00 · Class: 9.9%

  • VHCP Management III, LLC

    Shares: 11,805,301.00 · Class: 9.9%

  • VHCP Management EG, LLC

    Shares: 11,805,301.00 · Class: 9.9%

  • Nimish Shah

    Shares: 11,805,301.00 · Class: 9.9%

  • Bong Y Koh

    Shares: 11,805,301.00 · Class: 9.9%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001415889-25-004242
Form type
SCHEDULE 13G/A
Filer
Applied Therapeutics, Inc.
CIK
CIK 1697532
Filed
Feb 14, 2025
Reporting period
Dec 31, 2024
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub